Literature DB >> 18250250

Prospects for a genomic approach to the treatment of alcoholism.

Charles P O'Brien1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18250250     DOI： 10.1001/archgenpsychiatry.2007.32

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN： 0003-990X


× No keyword cloud information.
  8 in total

Review 1.  Review. Evidence-based treatments of addiction.

Authors:  Charles P O'Brien
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2008-10-12       Impact factor: 6.237

2.  Ethanol alters opioid regulation of Ca(2+) influx through L-type Ca(2+) channels in PC12 cells.

Authors:  Donna L Gruol; Thomas E Nelson; Christine Hao; Sarah Michael; Vladana Vukojevic; Yu Ming; Lars Terenius
Journal:  Alcohol Clin Exp Res       Date:  2011-10-20       Impact factor: 3.455

Review 3.  The role of the Asn40Asp polymorphism of the mu opioid receptor gene (OPRM1) on alcoholism etiology and treatment: a critical review.

Authors:  Lara A Ray; Christina S Barr; Julie A Blendy; David Oslin; David Goldman; Raymond F Anton
Journal:  Alcohol Clin Exp Res       Date:  2011-09-06       Impact factor: 3.455

4.  Naltrexone modification of drinking effects in a subacute treatment and bar-lab paradigm: influence of OPRM1 and dopamine transporter (SLC6A3) genes.

Authors:  Raymond F Anton; Konstantin K Voronin; Patrick K Randall; Hugh Myrick; Abraham Tiffany
Journal:  Alcohol Clin Exp Res       Date:  2012-05-02       Impact factor: 3.455

Review 5.  Penn/VA center for studies of addiction.

Authors:  Charles P O'Brien; A Thomas McLellan; Anna Rose Childress; George E Woody
Journal:  Neuropharmacology       Date:  2008-06-26       Impact factor: 5.250

6.  Gender differences in predictors of treatment attrition with high dose naltrexone in cocaine and alcohol dependence.

Authors:  Jesse J Suh; Helen M Pettinati; Kyle M Kampman; Charles P O'Brien
Journal:  Am J Addict       Date:  2008 Nov-Dec

7.  A preliminary pharmacogenetic investigation of adverse events from topiramate in heavy drinkers.

Authors:  Lara A Ray; Robert Miranda; James MacKillop; John McGeary; Jennifer W Tidey; Damaris J Rohsenow; Chad Gwaltney; Robert W Swift; Peter M Monti
Journal:  Exp Clin Psychopharmacol       Date:  2009-04       Impact factor: 3.157

8.  The Effects of Naltrexone Among Alcohol Non-Abstainers: Results from the COMBINE Study.

Authors:  Lara A Ray; Jennifer L Krull; Lorenzo Leggio
Journal:  Front Psychiatry       Date:  2010-10-12       Impact factor: 4.157
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.